Lung cancer pill cuts risk of death by half.
After surgery, the drug improved survival rates from 78% to 88%. “Overall, there was a 51% lower risk of death for those who received osimertinib compared with those who received placebo.” ~ learn more
After surgery, the drug improved survival rates from 78% to 88%. “Overall, there was a 51% lower risk of death for those who received osimertinib compared with those who received placebo.” ~ learn more